Ethyl 4-(1H-imidazol-1-yl)benzoate(CAS: 86718-07-2)

Ethyl 4-(1H-imidazol-1-yl)benzoate (CAS: 86718-07-2) falls under regulatory guidelines such as GHS classification, which includes health, environmental, and physical hazards. It is also subject to REACH regulations in the European Union, which require registration, evaluation, and authorization of chemical substances. Additionally, FDA and EPA requirements apply for its use in pharmaceuticals and agricultural products, respectively.

Several alternatives can be used in the synthesis of Ethyl 4-(1H-imidazol-1-yl)benzoate. Commonly, analogs such as Ethyl 4-(1H-pyrazol-1-yl)benzoate or Ethyl 4-(1H-tetrazol-1-yl)benzoate can be considered. Other substitute reagents include imidazoles with different substituents or different aromatic rings. The choice of alternative depends on desired properties and specific application requirements.

The market for Ethyl 4-(1H-imidazol-1-yl)benzoate (CAS: 86718-07-2) is growing due to its use in pharmaceuticals and as a precursor in organic synthesis. Research trends focus on its biological activity and potential applications in drug discovery. Price trends show a steady increase driven by growing demand and production costs. Emerging studies are exploring its use in developing new drug candidates and functional materials.

Waste containing Ethyl 4-(1H-imidazol-1-yl)benzoate (CAS: 86718-07-2) should be collected in appropriate containers and stored separately to prevent contamination. It should be incinerated or disposed of through professional waste disposal services. Environmental protection precautions include ensuring proper ventilation and personal protective equipment use during handling. Compliance with local hazardous waste regulations is mandatory.